Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of different treatment strategies in patients with chronic thromboembolic pulmonary hypertension: a single centre real-world experience.
Dardi F, Rotunno M, Guarino D, Suarez SM, Niro F, Loforte A, Taglieri N, Ballerini A, Magnani I, Bertozzi R, Donato F, Martini G, Manes A, Saia F, Pacini D, Galiè N, Palazzini M. Dardi F, et al. Among authors: taglieri n. Int J Cardiol. 2023 Nov 15;391:131333. doi: 10.1016/j.ijcard.2023.131333. Epub 2023 Sep 4. Int J Cardiol. 2023. PMID: 37673403
Predictors of 32P beta brachytherapy failure in patients with high-risk in-stent restenosis.
Ortolani P, Marzocchi A, Aquilina M, Gaiba W, Bunkheila F, Neri S, Lombardo E, Marrozzini C, Pini S, Taglieri N, Sbarzaglia P, Reggiani ML, Barbieri E, Branzi A. Ortolani P, et al. Among authors: taglieri n. Cardiovasc Radiat Med. 2004 Apr-Jun;5(2):77-83. doi: 10.1016/j.carrad.2004.06.005. Cardiovasc Radiat Med. 2004. PMID: 15464944 Clinical Trial.
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy.
Ortolani P, Marzocchi A, Aquilina M, Gaiba W, Neri S, Bunkheila F, Lombardo E, Pini S, Marrozzini C, Palmerini T, Taglieri N, Sbarzaglia P, Reggiani ML, Barbieri E, Branzi A. Ortolani P, et al. Among authors: taglieri n. Catheter Cardiovasc Interv. 2004 Dec;63(4):433-8. doi: 10.1002/ccd.20298. Catheter Cardiovasc Interv. 2004. PMID: 15558757
[Cystatin C and cardiovascular risk].
Taglieri N, Koenig W, Kaski JC. Taglieri N, et al. Ann Biol Clin (Paris). 2010 Sep-Oct;68(5):517-29. doi: 10.1684/abc.2010.0466. Ann Biol Clin (Paris). 2010. PMID: 20870574 Free article. Review. French.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
Cystatin C and cardiovascular risk.
Taglieri N, Koenig W, Kaski JC. Taglieri N, et al. Clin Chem. 2009 Nov;55(11):1932-43. doi: 10.1373/clinchem.2009.128397. Epub 2009 Aug 27. Clin Chem. 2009. PMID: 19713275 Review.
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Baldazzi F, Silenzi S, Taglieri N, Bacchi-Reggiani ML, Gordini G, Guastaroba P, Grilli R, Branzi A. Ortolani P, et al. Among authors: taglieri n. Am J Cardiol. 2007 Sep 1;100(5):787-92. doi: 10.1016/j.amjcard.2007.03.099. Epub 2007 Jun 13. Am J Cardiol. 2007. PMID: 17719321
112 results